Adam Lewandowski

Adam Lewandowski is the Deputy Chief Scientist for UK Biobank and an Associate Professor of Cardiovascular Science, based in the Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU). He completed his undergraduate studies in biological sciences at the University of Guelph in Canada, his Master’s degree in Healthcare Data at the University of Cambridge, and his DPhil in Cardiovascular Medicine at the University of Oxford.

After completing his DPhil in 2013, Adam was a postdoc researcher in the Division of Cardiovascular Medicine, University of Oxford and was subsequently awarded a British Heart Foundation Intermediate Basic Science Research Fellowship. His research has largely focused on using multi-modality, deep phenotyping approaches to identify early cardiac and vascular changes in young people at risk of cardiovascular disease. This includes how different early life development conditions, such as being born preterm or to a hypertensive pregnancy, affect long-term cardiovascular structure and function both at rest and under physiological stress conditions measured using modalities such as magnetic resonance imaging and echocardiography. 

Adam joined the UK Biobank scientific team in April 2024, where he is involved in developing the scientific strategy for future enhancements for the study, including the Brain Health study and cohort-wide repeat assessment.